Cantor Fitzgerald Lowers Allergan PLC. (NYSE:AGN) Price Target to $191.00

Allergan PLC. (NYSE:AGN) had its target price reduced by equities researchers at Cantor Fitzgerald to $191.00 in a note issued to investors on Thursday, November 2nd. The firm presently has a “neutral” rating on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 11.23% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on the stock. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $285.00 price objective on shares of Allergan PLC. in a research note on Wednesday, September 6th. Credit Suisse Group set a $243.00 price objective on shares of Allergan PLC. and gave the stock an “outperform” rating in a report on Tuesday, October 17th. Citigroup Inc. decreased their price objective on shares of Allergan PLC. from $280.00 to $240.00 and set a “buy” rating for the company in a report on Thursday, October 19th. BidaskClub lowered shares of Allergan PLC. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Finally, Wells Fargo & Company reaffirmed a “buy” rating on shares of Allergan PLC. in a report on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have given a buy rating to the company. Allergan PLC. currently has an average rating of “Hold” and a consensus price target of $246.73.

Allergan PLC. (NYSE:AGN) traded down $0.10 during midday trading on Thursday, hitting $171.72. 250,351 shares of the stock traded hands, compared to its average volume of 2,913,987. Allergan PLC. has a one year low of $169.61 and a one year high of $256.80. The company has a current ratio of 1.18, a quick ratio of 1.08 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $58,005.82, a price-to-earnings ratio of 11.31, a P/E/G ratio of 1.11 and a beta of 1.13.

Allergan PLC. (NYSE:AGN) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $4.15 EPS for the quarter, beating the consensus estimate of $4.06 by $0.09. Allergan PLC. had a negative net margin of 47.27% and a positive return on equity of 8.00%. The company had revenue of $4.03 billion during the quarter, compared to analysts’ expectations of $4.04 billion. During the same quarter in the previous year, the company earned $3.32 earnings per share. Allergan PLC.’s revenue for the quarter was up 11.4% on a year-over-year basis. equities research analysts expect that Allergan PLC. will post 16.28 earnings per share for the current fiscal year.

Allergan PLC. announced that its board has approved a share buyback program on Monday, September 25th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 2.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: “Cantor Fitzgerald Lowers Allergan PLC. (NYSE:AGN) Price Target to $191.00” was posted by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://baseballnewssource.com/markets/allergan-plc-agn-price-target-cut-to-191-00-by-analysts-at-cantor-fitzgerald/1750942.html.

A number of institutional investors and hedge funds have recently bought and sold shares of AGN. Fairbanks Capital Management Inc. raised its holdings in shares of Allergan PLC. by 20.9% in the third quarter. Fairbanks Capital Management Inc. now owns 6,627 shares of the company’s stock worth $1,358,000 after acquiring an additional 1,147 shares during the last quarter. Cubist Systematic Strategies LLC increased its stake in Allergan PLC. by 525.4% in the third quarter. Cubist Systematic Strategies LLC now owns 8,731 shares of the company’s stock valued at $1,789,000 after purchasing an additional 7,335 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in Allergan PLC. in the third quarter valued at $92,182,000. Bank of Nova Scotia Trust Co. increased its stake in Allergan PLC. by 33.4% in the third quarter. Bank of Nova Scotia Trust Co. now owns 6,003 shares of the company’s stock valued at $1,230,000 after purchasing an additional 1,503 shares during the last quarter. Finally, Zions Bancorporation increased its stake in Allergan PLC. by 1,115.6% in the third quarter. Zions Bancorporation now owns 936 shares of the company’s stock valued at $192,000 after purchasing an additional 859 shares during the last quarter. Institutional investors own 81.21% of the company’s stock.

About Allergan PLC.

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Analyst Recommendations for Allergan PLC. (NYSE:AGN)

Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with our FREE daily email newsletter.

 


Latest News

MLB Commissioner: New Rule for Pace-of-Play in 2018
MLB Commissioner: New Rule for Pace-of-Play in 2018
Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Brandon Morrow Becomes Hot Commodity
Brandon Morrow Becomes Hot Commodity


Leave a Reply

 
© 2006-2017 BBNS.